Eli Lilly is the leader in the GLP-1 space, but here's another GLP-1 stock and a medical device maker to consider.

Eli Lilly's full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit ...

Eli Lilly and Company (NYSE:LLY) is included among 13 Best Long Term Low Risk Stocks to Buy Now. On February 5, Goldman Sachs ...

Hims & Hers has a GLP-1 weight loss pill -- and it's the cheapest one out there.

The split in outlook underscores Lilly's strong position in the obesity market, underpinned by more effective drugs and its ...

Drugmaker Eli Lilly and Co. says it'll build a $3.5 billion manufacturing facility in Pennsylvania, as the company expands ...

The Lehigh Valley plant will be Indianapolis-based Lilly’s first manufacturing facility in Pennsylvania. Construction is ...

Pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) will open a $3.5 billion manufacturing facility in the Lehigh Valley community of Upper Macungie. The development will span about 925,000 square feet ...

Historical evidence indicates that abrupt market fluctuations can affect any corporation, regardless of its perceived dominance.

CEO of the company highlighted the multinational company's local philanthropic mission. Billions are giving away each year, and billions are donated yearly.

Eli Lilly is scheduled to report its fourth-quarter results before the market opens Wednesday. Here is what you need to know. PROFIT: Analysts polled by FactSet expect the company to post net income ...

Is there another beat-and-raise in the pharmaceutical giant's near future?